↓ Skip to main content

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells

Overview of attention for article published in BMC Pharmacology and Toxicology, September 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
Published in
BMC Pharmacology and Toxicology, September 2013
DOI 10.1186/2050-6511-14-48
Pubmed ID
Authors

R Preston Mason, Robert F Jacob, J Jose Corbalan, Damian Szczesny, Kinga Matysiak, Tadeusz Malinski

Abstract

Nebivolol is a third-generation beta-blocker used to treat hypertension. The vasodilation properties of nebivolol have been attributed to nitric oxide (NO) release. However, the kinetics and mechanism of nebivolol-stimulated bioavailable NO are not fully understood.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 26%
Researcher 4 17%
Student > Doctoral Student 3 13%
Student > Bachelor 3 13%
Student > Master 2 9%
Other 2 9%
Unknown 3 13%
Readers by discipline Count As %
Medicine and Dentistry 6 26%
Chemistry 5 22%
Agricultural and Biological Sciences 5 22%
Biochemistry, Genetics and Molecular Biology 2 9%
Psychology 1 4%
Other 1 4%
Unknown 3 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2013.
All research outputs
#20,203,867
of 22,723,682 outputs
Outputs from BMC Pharmacology and Toxicology
#365
of 438 outputs
Outputs of similar age
#179,250
of 204,835 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#14
of 14 outputs
Altmetric has tracked 22,723,682 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 438 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,835 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.